Back to News
Market Impact: 0.42

Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock

Source: CNBC

Interest Rates & YieldsMonetary PolicyInflationEnergy Markets & PricesMarket Technicals & FlowsCorporate EarningsCompany FundamentalsCapital Returns (Dividends / Buybacks)
Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock

The 10-year Treasury yield climbed to 5.34%, its highest level since 2002, after hotter-than-expected ISM prices-paid data reinforced expectations of another Fed rate increase; WTI crude also rose above $92 per barrel. Cramer said elevated yields could keep equities under pressure despite the S&P Oscillator reaching an oversold -5.1%. Micron fell despite a strong quarter, as investors focused on gross-margin and capacity-spending risks, although its 26 strategic customer agreements and a potential December buyback support its longer-term outlook. Cardinal Health rose more than 3% after extending its CVS distribution agreement through June 2032 and reaffirming fiscal 2027 adjusted EPS growth of 13%-15%.

Analysis

MU’s near-term setup is a classic earnings-quality versus duration trade: investors are discounting the risk that capacity spending converts an improving memory cycle into renewed oversupply before earnings fully recover. The key distinction is whether incremental capex is directed toward technically constrained HBM/leading-edge DRAM rather than commodity bits; if so, Samsung and SK Hynix face a more difficult catch-up curve while legacy NAND pricing remains the weak link. Over the next 1-3 months, MU likely remains highly correlated to real yields and semiconductor momentum, but a sustained improvement in DRAM contract pricing and gross-margin progression would matter more than the customer-agreement count.

A future buyback would be supportive to MU’s downside only if management funds it from excess cash after maintaining technology leadership; repurchasing shares while capex rises is not intrinsically accretive in a cyclical industry. The falsification point is a sequential gross-margin stall or a material increase in industry wafer starts, which would indicate that supply discipline has broken. Conversely, a lower-yield macro print could create a sharp relief rally in long-duration semis before fundamentals change.

CAH’s contract visibility reduces the probability of an immediate distribution-margin reset, but it also crystallizes concentration risk: a single large customer retains negotiating leverage when the agreement next resets. The more investable implication is relative: CAH has earnings-duration support from execution and capital return, while CVS still must prove that its broader medical-cost and utilization pressures do not absorb the value created by stable distribution economics. MCK remains the cleaner peer hedge because its earnings mix and customer exposure are not identical, limiting the value of a simple sector-wide long.

Higher real rates and energy-driven inflation are unfavorable for rate-sensitive cyclicals even where operating demand is intact. TOL may retain better relative resilience than lower-end housing because affluent buyers are less payment constrained, but its multiple is vulnerable if mortgage rates stay elevated for another 1-3 months; this is a macro valuation trade, not yet a housing-demand short.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

-0.12

Ticker Sentiment

CAH0.78
CVS0.28
MCK0.12
MU0.48

Key Decisions for Investors

  • Accumulate MU only in tranches on semiconductor weakness over the next 1-3 months; pair with a partial SOXX hedge if real yields remain elevated. Target a 12-18 month recovery in memory profitability, but reduce exposure on a sequential gross-margin miss or evidence of broad DRAM/NAND capacity additions.
  • Prefer a CAH/MCK relative long over an outright CAH chase after the initial repricing: initiate on a 3-5% pullback and hold through the next earnings report. The thesis is that CAH’s earnings-risk discount narrows; exit if its fiscal growth framework is diluted or operating-margin commentary implies customer concessions.
  • Avoid treating a potential MU buyback as a standalone catalyst until authorization size, timing, and capex funding are disclosed. Set an alert for capital-return details and for HBM/DRAM mix data; absent those, the risk/reward is driven primarily by memory pricing rather than financial engineering.
  • Maintain an underweight or tactical put-spread hedge in TOL versus a long CAH position for the next 1-3 months if the 10-year yield remains above recent breakout levels. Cover the hedge if yields retrace materially following softer inflation or labor data, since housing equities can rebound quickly on rate relief.

More News

From AllMind Research

Browse all research